BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217117. A total of 57 filers reported holding BIOPLUS ACQUISITION CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $8,182,183 | +3744.0% | 783,734 | +3677.8% | 0.17% | +3260.0% |
Q4 2022 | $212,854 | +2.3% | 20,746 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $208,000 | 0.0% | 20,746 | +0.1% | 0.01% | 0.0% |
Q2 2022 | $208,000 | +1.5% | 20,733 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $205,000 | – | 20,733 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Telemetry Investments, L.L.C. | 66,607 | $685 | 1.08% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,482,836 | $15,244 | 0.42% |
MMCAP International Inc. SPC | 400,000 | $4,088,000 | 0.42% |
CANTOR FITZGERALD, L. P. | 1,422,204 | $14,557 | 0.31% |
KIM, LLC | 500,000 | $5,140 | 0.28% |
Spartan Fund Management Inc. | 74,485 | $763 | 0.28% |
Saba Capital Management, L.P. | 1,791,845 | $18,384,330 | 0.25% |
Atalaya Capital Management LP | 125,000 | $1,285,000 | 0.23% |
Radcliffe Capital Management, L.P. | 555,355 | $5,697,942 | 0.18% |
Exos TFP Holdings LLC | 62,500 | $638,750 | 0.18% |